The following is a list of 43 cGMP warning letters issued to drug manufacturers, biologics manufacturers, testing laboratories, cosmetics manufacturers, compounding pharmacies and repackagers during the fiscal year that ended Sept. 30, 2013. The warning letters are categorized according to the type of drug product involved (topical, active ingredients, injectable, oral solid, oral liquid, therapeutic biologic and miscellaneous). Warning letters that target two types of products, such as APIs and solid oral dosage forms, went into the miscellaneous category and are counted once. The listing provides the recipient’s name, the location of the inspected facility, the date the warning letter was issued and the date of the inspection, followed by a description of the GMP area(s) addressed in the letter.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?